AntiCoagAF
AntiCoagAF generates an estimated $0/month in revenue from 0 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-08-02).
| Est. revenue / month | $0 |
|---|---|
| Est. downloads / month | 0 |
| Estimate confidence | low |
| Pricing | Paid $1.99 |
| Rating | 0.00 ★ (0 ratings) |
| Category | Medical |
| Released | 26.11.2013 |
| App last updated | 31.03.2025 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · low confidence
About
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF). It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban. Topics covered include: comparison of anticoagulants, patient information,…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 11Ratings & velocity
★ 0 in windowGeographic reach
best rank · 0 storefrontsRevenue & downloads trend
monthly estimateUpdate history
1 update tracked- v1.3.21.4y ago
Miscellaneous bug fixes and updated for iOS 16+.
AntiCoagAF — FAQ
How many downloads does AntiCoagAF get?
AntiCoagAF sees an estimated 0 downloads per month on the App Store, per AppCurrents modeling.
Is AntiCoagAF free?
AntiCoagAF is a paid app priced at $1.99 on the App Store.
When was AntiCoagAF released?
AntiCoagAF launched on the App Store on 26.11.2013. Its latest version shipped 31.03.2025.
